Cordero Leandro, Ayers Leona W
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio 43210-1228, USA.
Infect Control Hosp Epidemiol. 2003 Sep;24(9):662-6. doi: 10.1086/502270.
To study multicenter antibiotic practices for suspected early-onset sepsis (EOS) with negative blood cultures (NegBCs) and to identify opportunities for reduction of antimicrobial exposure.
Retrospective study.
Thirty academic hospitals (University HealthSystem Consortium) located in 24 states.
Data were from a survey of 790 extremely low birth weight (ELBW) infants. Total antibiotic exposures (antibiotic-days per patient) were calculated.
On admission to the NICU, 94% of 790 ELBW infants had BCs performed and empiric antibiotics initiated. When PosBC and NegBC infants were compared, 47 patients with PosBCs were similar to 695 with NegBCs in birth weight, gestational age (GA), and mortality. Patients with suspected EOS but NegBCs given ampicillin/aminoglycosides were grouped by length of administration and GA. For GA of 26 weeks or younger, 170 infants given a short (< or = 3 days) and 157 given a long (> or = 7 days) course were similar regarding birth weight, mortality, antepartum history, and CRIB scores, but were different (P < .01) in number receiving a third antimicrobial (3% and 17%) and antibiotic-days (23 and 38). For GA of 27 weeks or older, 113 infants given a short and 77 given a long course differed (P < .01) in number receiving a third antimicrobial (2% and 23%) and antibiotic-days (19 and 30).
Most suspected EOS infants with NegBCs are given antibiotics, but no antepartum historical risk factors or neonatal clinical signs explained prolonged administration. Discontinuing empiric antibiotics when BCs are negative in asymptomatic ELBW infants can reduce antimicrobial exposure without compromising clinical outcome.
研究多中心针对血培养阴性(NegBCs)的疑似早发型败血症(EOS)的抗生素使用情况,并确定减少抗菌药物暴露的机会。
回顾性研究。
位于24个州的30家学术医院(大学卫生系统联盟)。
数据来自对790例极低出生体重(ELBW)婴儿的调查。计算总的抗生素暴露量(每位患者的抗生素使用天数)。
在入住新生儿重症监护病房(NICU)时,790例ELBW婴儿中有94%进行了血培养并开始使用经验性抗生素。比较血培养阳性(PosBC)和血培养阴性(NegBC)的婴儿时,47例血培养阳性患者在出生体重、胎龄(GA)和死亡率方面与695例血培养阴性患者相似。给予氨苄西林/氨基糖苷类药物的疑似EOS但血培养阴性的患者按用药时长和胎龄分组。对于胎龄26周或更小的婴儿,170例接受短疗程(≤3天)和157例接受长疗程(≥7天)的婴儿在出生体重、死亡率、产前病史和CRIB评分方面相似,但在接受第三种抗菌药物的人数(3%和17%)和抗生素使用天数(23天和38天)方面存在差异(P<.01)。对于胎龄27周或更大的婴儿,113例接受短疗程和77例接受长疗程的婴儿在接受第三种抗菌药物的人数(2%和23%)和抗生素使用天数(19天和30天)方面存在差异(P<.01)。
大多数血培养阴性的疑似EOS婴儿接受了抗生素治疗,但产前历史风险因素或新生儿临床体征均无法解释为何延长用药。对于无症状的ELBW婴儿,当血培养为阴性时停用经验性抗生素可减少抗菌药物暴露,且不影响临床结局。